Liminal BioSciences
✓ VerifiedPlasma-derived therapeutics and small molecules
📊
$42M
Annual Revenue
👥
200
Employees
📦
8
Products
68%
68%
Profile Completeness
📄 About Liminal BioSciences
Liminal BioSciences develops small molecule treatments targeting GPR84 receptor for inflammatory bowel disease and other fibrotic conditions alongside plasma-derived protein therapies.
🛡️
High Quality
Products
Products
🌐
Global
Distribution
Distribution
💡
Innovative
Technology
Technology
👥
Customer
Focused
Focused
📦 Featured Products
View All Products →
No products currently listed for Liminal BioSciences.
📍 Location & Offices
View on Map
🗺️
Laval, Canada
📋 Request a Quote
Send your requirements directly to Liminal BioSciences. Response typically within 48 hours.
